Press Releases

BASKING RIDGE, N.J., Aug. 12, 2019 /PRNewswire/ -- Daiichi Sankyo, Inc. ("the Company") today announced the appointment of Simon King as Chief People Officer, effective August 12, 2019. This newly created role combines previously existing leadership positions within the Company's Human Resources function

ROCKVILLE, Md., Aug. 12, 2019 /PRNewswire/ -- CNSI, a leading business solutions provider with vast experience developing and delivering innovative health information technology solutions, announced today t

RIDGEFIELD, Conn. and HOUSTON, Aug. 12, 2019 /PRNewswire/ -- Boehringer Ingelheim and The University of

SAN DIEGO, Aug. 12, 2019 /PRNewswire/ -- Aya Healthcare, the company transforming

SEOUL, South Korea, Aug. 12, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in development and market of innovative molecular diagnostics, announced the publication of a new study on Frontiers in Oncology comparing GenesWell™ BCT, a prognostic multigene test, with Genomic Health's Oncotype DX in patients with early-stage breast cancer. This is the

OSLO, Norway, Aug. 12, 2019 /PRNewswire/ -- CardioMech AS, a privately-held company developing a transcatheter mitral valve repair technology, announced today that it has closed on a

STOCKHOLM, Aug. 12, 2019 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that it has exclusively in-licensed Budenofalk 3mg oral capsule for the US market from the German pharmaceutical company Dr. Falk Pharma GmbH ("Dr. Falk"). The agreement covers all indications for the US market, excluding orphan indications outside of liver targe

SEATTLE, Aug. 12, 2019 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense announced today that Kineta's management team has been invited to participate at Solebury Trout's 9th Annual CEO Roundtable Conference in Bridgehampton, NY. 

BOSTON, Aug. 12, 2019 /PRNewswire/ --  binx health, the pioneer in anywhere, anytime testing for women's health, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its first-of-kind, highly sensitive and specific, molecular point-of-care (POC) diagnostic testing platform, the binx io®

NEW YORK and CAESAREA, Israel, Aug. 12, 2019 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (